205 WEST 28TH STREET, NEW YORK, NY, UNITED STATES, 10001
國家
美國
上市日期
2025-07-02
財年截止
十二月
流通股數
21.56M
CIK
--
官方網址
--
1RT Acquisition Corp. 公司總部位於紐約州紐約市。
財務指標
營業收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
營業支出
2026-06-30
$145.26K
2026-03-31
$172.51K
2025-12-31
$117.06K
2025-09-30
$285.19K
淨利潤
2026-06-30
$1.42M
2026-03-31
$1.37M
2025-12-31
$1.56M
2025-09-30
$1.39M
淨利潤率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$0.06
2026-03-31
$0.06
2025-12-31
$0.07
2025-09-30
$0.07
息稅折舊攤銷前利潤
2026-06-30
-$145.26K
2026-03-31
-$172.51K
2025-12-31
-$117.06K
2025-09-30
$1.39M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$0
$0
$0
$0
營業支出
$145.26K
$172.51K
$117.06K
$285.19K
淨利潤
$1.42M
$1.37M
$1.56M
$1.39M
淨利潤率
--
--
--
--
每股收益
$0.06
$0.06
$0.07
$0.07
息稅折舊攤銷前利潤
-$145.26K
-$172.51K
-$117.06K
$1.39M
有效稅率
--
--
--
--
常見問題
ONCH represents the publicly traded equity of Onconetix, Inc., a company focused on developing and commercializing diagnostic and therapeutic solutions in oncology and related healthcare markets. Shares trade on a U.S. exchange under the ticker ONCH. Investors commonly track ONCH to gain exposure to the company's product pipeline, strategic partnerships, and commercial-stage efforts. Because it is a smaller-cap healthcare name, ONCH can be sensitive to clinical, regulatory, and financing developments.
The latest ONCH stock price is shown on the ONCH stock detail page, along with real-time or delayed quotes, daily price changes, volume, and charting data. For the most current price, you should refer to that page or your brokerage platform. If you need precise figures such as intraday highs, lows, and recent trades, rely on the live market data displayed there rather than fixed or historical numbers.
Several factors can influence ONCH stock, including clinical trial results, regulatory decisions, product commercialization progress, partnership or licensing news, and capital-raising activities. Broader healthcare-sector sentiment, changes in reimbursement or drug-pricing policy, and general market conditions can also affect the shares. Because ONCH has a relatively limited revenue base, company-specific announcements often have an outsized impact on the stock's trading behavior compared with larger, more diversified healthcare peers.
Valuation for ONCH is typically assessed using metrics such as price-to-sales, price-to-book, enterprise value, and cash position, since early-stage healthcare companies may not have meaningful earnings. Analysts may also consider pipeline potential, addressable market size, and partnership economics, though these are qualitative and harder to benchmark. Investors should review the latest ONCH data on the page and compare it with peer companies, while recognizing that clinical-stage names can trade on future prospects rather than current fundamentals.
You can buy ONCH stock through a brokerage account that offers access to U.S. equity markets. Once your account is funded, you can place a market or limit order for ONCH shares during regular trading hours. Some brokers also support extended-hours trading and fractional shares, subject to their policies. Before trading, check commissions, order types, and any eligibility requirements, and confirm the latest ONCH quote on the stock detail page for current pricing.
Key risks include clinical and regulatory uncertainty, dependence on a limited number of product candidates, potential need for additional financing, and competition from larger healthcare companies. ONCH may also face manufacturing, reimbursement, and commercialization risks. Because the company is relatively small, its shares can be more volatile and less liquid than larger peers, and negative news on trials, partnerships, or financials could disproportionately affect the stock price.